| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 33,006 | 33,510 | 34,460 | 42,318 | | Cost of Revenue | 25,306 | 22,474 | 22,366 | 26,291 | | | Gross Profit | 7,700 | 11,036 | 12,094 | 16,027 | | | Operating Expenses | | Research Development | 1,379 | 1,164 | 1,260 | 1,447 | | Selling General and Administrative | 11,222 | 13,205 | 12,337 | 14,701 | | Non Recurring | 1,040 | 19,152 | 84 | 539 | | Others | 225 | 233 | 254 | 261 | | | | Total Operating Expenses | 13,866 | 33,754 | 13,935 | 16,948 | | | | Operating Income or Loss | (6,166) | (22,718) | (1,841) | (921) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (122) | 534 | 1,720 | | Earnings Before Interest And Taxes | (7,109) | (22,840) | (1,307) | 799 | | Interest Expense | (198) | 124 | 74 | 136 | | Income Before Tax | (6,911) | (22,964) | (1,381) | 663 | | Income Tax Expense | (264) | 16,905 | (275) | 49 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,647) | (39,869) | (1,106) | 614 | | | Non-recurring Events | | Discontinued Operations | 706 | (1,580) | (85) | (1,070) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,941) | (41,449) | (1,191) | (456) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,941) | ($41,449) | ($1,191) | ($456) |
|
0.30% Nasdaq 
0.49%
Income Statement
